BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31417637)

  • 1. Surgical Resection plus Radiofrequency Ablation versus Radical Surgery for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
    Zhou C; Zhang X; Peng Y; Zhou K; Hu J; Yu L; Chen F; Qiu S; Zhou J; Fan J; Zhang L; Wang Z
    J Cancer; 2019; 10(17):3933-3940. PubMed ID: 31417637
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
    Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical resection plus radiofrequency ablation for the treatment of multifocal hepatocellular carcinoma.
    Zhou C; Peng Y; Zhou K; Zhang L; Zhang X; Yu L; Hu J; Chen F; Qiu S; Zhou J; Fan J; Ren Z; Wang Z
    Hepatobiliary Surg Nutr; 2019 Feb; 8(1):19-28. PubMed ID: 30881962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical resection versus radiofrequency ablation very early-stage HCC (≤2 cm Single HCC): A propensity score analysis.
    Chu HH; Kim JH; Kim PN; Kim SY; Lim YS; Park SH; Ko HK; Lee SG
    Liver Int; 2019 Dec; 39(12):2397-2407. PubMed ID: 31549771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria.
    Takuma Y; Takabatake H; Morimoto Y; Toshikuni N; Kayahara T; Makino Y; Yamamoto H
    Radiology; 2013 Dec; 269(3):927-37. PubMed ID: 24086071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
    Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
    J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients.
    Hocquelet A; Balageas P; Laurent C; Blanc JF; Frulio N; Salut C; Cassinotto C; Saric J; Possenti L; Bernard PH; Montaudon M; Trillaud H
    Int J Hyperthermia; 2015; 31(7):749-57. PubMed ID: 26365503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Radiofrequency Ablation vs. Surgical Resection for Patients With Solitary Hepatocellular Carcinoma Smaller Than 5 cm.
    Zheng L; Zhang CH; Lin JY; Song CL; Qi XL; Luo M
    Front Oncol; 2020; 10():399. PubMed ID: 32296638
    [No Abstract]   [Full Text] [Related]  

  • 11. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy
    Yi PS; Huang M; Zhang M; Xu L; Xu MQ
    Am Surg; 2018 Feb; 84(2):282-288. PubMed ID: 29580359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Combined Transcatheter Arterial Chemoembolization and CT-guided Radiofrequency Ablation with Surgical Resection in Patients with Hepatocellular Carcinoma within the Up-to-seven Criteria: A Multicenter Case-matched Study.
    Pan T; Mu LW; Wu C; Wu XQ; Xie QK; Li XS; Lyu N; Li SL; Deng HJ; Jiang ZB; Lin AH; Zhao M
    J Cancer; 2017; 8(17):3506-3513. PubMed ID: 29151935
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Surgical Resection and Percutaneous Ultrasonographic Guided Radiofrequency Ablation for Initial Recurrence of Hepatocellular Carcinoma in Early Stage following Curative Treatment.
    Ohama H; Hiraoka A; Tada F; Kato K; Fukunishi Y; Yanagihara E; Kato M; Saneto H; Izumoto H; Ueki H; Yoshino T; Kitahata S; Kawamura T; Kuroda T; Suga Y; Miyata H; Hirooka M; Abe M; Matsuura B; Ninomiya T; Hiasa Y
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analyses.
    Lee YH; Hsu CY; Chu CW; Liu PH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
    J Clin Gastroenterol; 2015 Mar; 49(3):242-9. PubMed ID: 24714185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
    Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK;
    Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure laparoscopic liver resection versus percutaneous radiofrequency ablation for small hepatocellular carcinoma: a propensity score and multivariate analysis.
    Cheng KC; Ho KM
    Transl Cancer Res; 2022 Jan; 11(1):43-51. PubMed ID: 35261883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single Hepatocellular Carcinoma approached by curative-intent treatment: A propensity score analysis comparing radiofrequency ablation and liver resection.
    Di Sandro S; Benuzzi L; Lauterio A; Botta F; De Carlis R; Najjar M; Centonze L; Danieli M; Pezzoli I; Rampoldi A; Bagnardi V; De Carlis L
    Eur J Surg Oncol; 2019 Sep; 45(9):1691-1699. PubMed ID: 31072620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Uhlig J; Sellers CM; Stein SM; Kim HS
    Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.